A comparison of flow cytometry and immunohistochemistry in human colorectal cancers

In human colorectal cancer it has been reported that some tumours lack the HLA‐ABC antigens. This has been interpreted as reflecting tumour escape from the immune system. Earlier data have been obtained by immunohistochemistry. In this study, we compared the expression of HLA‐ABC, HLA‐DR, CD80 (B7–1) and CD54 (ICAM‐1) in 20 tumours using both a conventional immunohistochemistry two‐layer technique and multiparameter flow cytometry, gating on an epithelial cell marker. Colorectal cancer tissue used in flow cytometry was dissociated with collagenase, deoxyribonuclease and hyaluronidase. The intensity of expression of HLA‐ABC, HLA‐DR and CD80 was unaffected by the enzymes, but CD54 was decreased by 30%. The reproducibility of flow cytometry was good. Microscopy of sections revealed that about 5% of each tumour sample consisted of normal epithelium, but even after correction for this, flow cytometry was superior to immunohistochemistry in 33 out of 80 cases, and showed that tumours described as HLA‐ABC negative by immunohistochemistry were in fact weakly positive for HLA‐ABC. We conclude that flow cytometry and immunohistochemistry are complementary, and that flow cytometry is superior to immunohistochemistry for detecting anti‐gens/epitopes present in low amounts.

[1]  C. Feighery,et al.  Collagenase and Dispase enzymes disrupt lymphocyte surface molecules. , 1996, Journal of immunological methods.

[2]  J. Sedgwick,et al.  Tissue digestion with dispase substantially reduces lymphocyte and macrophage cell-surface antigen expression. , 1996, Journal of immunological methods.

[3]  S. Wingren,et al.  Loss of cytokeratins in breast cancer cells using multiparameter DNA flow cytometry is related to both cellular factors and preparation procedure. , 1995, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[4]  B. Brandt,et al.  Immunophenotyping of lymphocytes in bronchoalveolar lavage fluid. A new flow cytometric method vs standard immunoperoxidase technique. , 1995, Chest.

[5]  H. Zola,et al.  Cytokine receptor expression in human lymphoid tissue: analysis by fluorescence microscopy. , 1995, Disease markers.

[6]  B. Coventry,et al.  A comparison of the sensitivity of immunoperoxidase staining methods with high-sensitivity fluorescence flow cytometry-antibody quantitation on the cell surface. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[7]  W. Dippold,et al.  Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells. , 1993, Gut.

[8]  J. Bodmer,et al.  Tumor Escape from Immune Response by Variation in HLA Expression and Other Mechanisms , 1993, Annals of the New York Academy of Sciences.

[9]  T. Rognum,et al.  Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. , 1993, British Journal of Cancer.

[10]  H. Brady,et al.  Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro. , 1992, American Journal of Physiology.

[11]  A. Harris,et al.  Loss of HLA class‐I alleles, heavy chains and β2‐microglobulin in colorectal cancer , 1992, International journal of cancer.

[12]  J. Monaco,et al.  A molecular model of MHC class-I-restricted antigen processing. , 1992, Immunology today.

[13]  H. Ploegh,et al.  Intracellular transport of MHC class II molecules. , 1992, Immunology today.

[14]  K. Koretz,et al.  Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma. , 1991, Cancer research.

[15]  H. Zola,et al.  Detection by immunofluorescence of surface molecules present in low copy numbers. High sensitivity staining and calibration of flow cytometer. , 1990, Journal of immunological methods.

[16]  M. R. Oliva,et al.  K‐ras mutations (codon 12) are not involved in down‐regulation of mhc class‐i genes in colon carcinomas , 1990, International journal of cancer.

[17]  H. Stein,et al.  Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. , 1990, Journal of clinical pathology.

[18]  A. Ghosh,et al.  MHC status of primary human colorectal carcinoma: biological significance and implications for host immune recognition. , 1989, Acta chirurgica Scandinavica. Supplementum.

[19]  R. W. Baldwin,et al.  Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression. , 1987, British Journal of Cancer.

[20]  P. Möller,et al.  Loss of HLA‐A,B,C and de novo expression of HLA‐D in colorectal cancer , 1986, International journal of cancer.

[21]  S. Hsu,et al.  Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. , 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[22]  G. Moore,et al.  Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. , 1978, Cancer research.

[23]  F. R. Watson,et al.  Cancer of the colon: the influence of the no-touch isolation technic on survival rates. , 1967, Annals of surgery.

[24]  Road,et al.  The Spread of Rectal Cancer and its Effect on Prognosis , 1958, British Journal of Cancer.

[25]  H. Stein,et al.  Ber-EP 4 : new monoclonal antibody which distinguishes epithelia from mesothelia , 2022 .